Trials / Completed
CompletedNCT02347046
Clinical Pharmacology of FYU-981 (Subjects With Renal Insufficiency)
Clinical Pharmacology Study of FYU-981 for Subjects With Renal Insufficiency.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Fuji Yakuhin Co., Ltd. · Industry
- Sex
- Male
- Age
- 20 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the pharmacokinetics, pharmacodynamics and safety after single oral administration of FYU-981 to subjects with renal insufficiency and with normal renal function.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | FYU-981, (Oral single dosing) | FYU-981, (Oral single dosing) |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2015-03-01
- Completion
- 2015-03-01
- First posted
- 2015-01-27
- Last updated
- 2015-03-06
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02347046. Inclusion in this directory is not an endorsement.